LLY’s Oral GLP-1 Pill Scores Another Pair of Diabetes Wins
Eli Lilly LLY announced positive top-line data from two late-stage studies evaluating orforglipron, its once-daily oral GLP-1 pill, in…
Concentrated Exercise, Home BP Monitoring, & More
Welcome to Med Op-Ed, where we highlight recently published editorials. In this installment: New research challenges guidelines that…